Literature DB >> 21544685

Glycyrrhiza glabra (Linn.) and Lavandula officinalis (L.) cell suspension cultures-based biotransformation of β-artemether.

Suman Patel1, Rashmi Gaur, Mohita Upadhyaya, Archana Mathur, Ajay K Mathur, Rajendra S Bhakuni.   

Abstract

The biotransformation of β-artemether (1) by cell suspension cultures of Glycyrrhiza glabra and Lavandula officinalis is reported here for the first time. The major biotransformed product appeared as a grayish-blue color spot on thin-layer chromatography (TLC) with transparent crystal-like texture. Based on its infrared (IR) and (1)H nuclear magnetic resonance (NMR) spectra, the product was characterized as a tetrahydrofuran (THF)-acetate derivative (2). The highest conversion efficiencies of 57 and 60% were obtained when 8-9-day-old cell suspensions of G. glabra and L. officinalis were respectively fed with 4-7 mg of compound 1 in 40 ml of medium per culture and the cells were harvested after 2-5 days of incubation. The addition of compound 1 at the beginning of the culture cycle caused severe growth depression in a dose-dependent manner, resulting in poor bioconversion efficiency of ~25% at 2-5 mg/culture dose only.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544685     DOI: 10.1007/s11418-011-0539-5

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  17 in total

1.  Biotransformations using plant cells, organ cultures and enzyme systems: current trends and future prospects.

Authors:  A Giri; V Dhingra; C C Giri; A Singh; O P Ward; M L Narasu
Journal:  Biotechnol Adv       Date:  2001-06       Impact factor: 14.227

Review 2.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 3.  Progress in the research of artemisinin and its analogues as antimalarials: an update.

Authors:  Dharmarajan Sriram; Vajja Sambasiva Rao; Kondapalli Venkata Gowri Chandrasekhara; Perumal Yogeeswari
Journal:  Nat Prod Res       Date:  2004-12       Impact factor: 2.861

Review 4.  Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action.

Authors:  J N Cumming; P Ploypradith; G H Posner
Journal:  Adv Pharmacol       Date:  1997

Review 5.  Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.

Authors:  Devdutt Chaturvedi; Abhishek Goswami; Partha Pratim Saikia; Nabin C Barua; Paruchuri G Rao
Journal:  Chem Soc Rev       Date:  2009-08-24       Impact factor: 54.564

Review 6.  Artemisinin: mechanisms of action, resistance and toxicity.

Authors:  Steven R Meshnick
Journal:  Int J Parasitol       Date:  2002-12-04       Impact factor: 3.981

Review 7.  Artemisinin and its derivatives: an important new class of antimalarial agents.

Authors:  G A Balint
Journal:  Pharmacol Ther       Date:  2001 May-Jun       Impact factor: 12.310

8.  Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.

Authors:  Andreas Mårtensson; Johan Strömberg; Christin Sisowath; Mwinyi I Msellem; J Pedro Gil; Scott M Montgomery; Piero Olliaro; Abdullah S Ali; Anders Björkman
Journal:  Clin Infect Dis       Date:  2005-09-13       Impact factor: 9.079

9.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Authors:  Arjen Dondorp; François Nosten; Kasia Stepniewska; Nick Day; Nick White
Journal:  Lancet       Date:  2005 Aug 27-Sep 2       Impact factor: 79.321

Review 10.  Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.

Authors:  Mankil Jung; Kyunghoon Lee; Hanjo Kim; Moonsoo Park
Journal:  Curr Med Chem       Date:  2004-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.